Atika Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Atika Capital Management's BMY Position: Q1 2016 in Review
Atika Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2016, closing a stake of 62,500 shares — an estimated $4.3M sold.
Atika Capital Management first reported a position in BMY in Q3 2015 and held it in 2 quarters. The position peaked at $4.3M in Q4 2015. 1,523 funds tracked by Wall St. Rank hold BMY as of Q1 2016.
- Atika Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2016 after selling out during the quarter.
- Atika Capital Management sold 62,500 Bristol-Myers Squibb shares in Q1 2016, an estimated $4.3M.
- Atika Capital Management first reported a position in Bristol-Myers Squibb in Q3 2015 and held it in 2 quarters.
- Atika Capital Management's Bristol-Myers Squibb position peaked at $4.3M in Q4 2015.
- 1,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2016.
Based on Atika Capital Management's 13F filing for Q1 2016, filed 16 May 2016.